Since this molecular event precedes tissue morphological alterations, especially in groups at risk of developing this disease, epigenetic-silencing of TFF1 has a potential for application in ESCC early diagnosis. The gene discussed is TFF1; the disease is esophageal squamous cell carcinoma.